Ignacio S. De La Riva-De La Cueva

Sevilla, AN, ES 
Sevilla, AN, ES 

Overview

Ignacio De La Riva-De La Cueva practices practicing medicine in Sevilla, Spain.

His clinical expertise encompasses Human Papillomavirus Infection, Hypothermia, Diphtheria, and Tetanus.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Sevilla, AN, Spain
Other Locations
CSIC
Madrid, MD, Spain
Huelva, AN 21819, Spain
Spain
Ibiza, PM 07800, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine When Administered to Healthy Infants
A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine When Administered to Healthy Infants
Enrollment Status: Completed
Publish Date: June 26, 2026
Intervention Type: Combination product
Study Phase: Phase 2
Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccines
Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccines
Enrollment Status: Completed
Publish Date: January 05, 2024
Intervention Type: Other
Study Phase: Phase 4
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Immunogenicity, Reactogenicity and Safety Study of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) When Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age
Immunogenicity, Reactogenicity and Safety Study of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) When Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age
Enrollment Status: Completed
Publish Date: February 17, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

42 Total Publications

Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.
Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.
Journal: Frontiers in nutrition
Published: July 30, 2025

Frequently Asked Questions about Ignacio S. De La Riva-De La Cueva

Is Ignacio S. De La Riva-De La Cueva a top-rated expert for Human Papillomavirus Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Ignacio S. De La Riva-De La Cueva is classified as an Experienced expert for Human Papillomavirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ignacio S. De La Riva-De La Cueva participate in research or clinical trials?

Yes. Ignacio S. De La Riva-De La Cueva has published 42 articles and abstracts on conditions like Human Papillomavirus Infection. You can view a list of Ignacio S. De La Riva-De La Cueva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De La Riva-De La Cueva's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile